Exscientia was founded with the mission of transforming drug discovery and development through the application of advanced Artificial Intelligence (AI) and automation technologies. The company was established in 2012 with pioneering AI technology from the University of Glasgow, and a core of experienced drug discovery and development experienced scientists. In 2020, Exscientia was awarded the prestigious Clerks Award, given to companies that have demonstrated innovation in the drug discovery field.
